drugset / Trial / NCT00231725

Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin

NCT00231725

Phase 3 Completed 370 enrolled Eli Lilly and Company
Non-randomizedSingle-groupOpen-label

Summary

Trial of new insulin injection pen called Pre-filled Pen B by type 2 diabetics in take home situations. Patients must use insulin lispro injection \[rDNA origin\] Low Mix twice daily during the trial.

Timeline

Start
2005-09
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Background Insulin Lispro Protein / enzyme biologic